🌿 Environment 3d ago · Gwendolyn Wu

A PureTech startup banks $180M for a new IPF drug

BioPharma Dive
BioPharma industry news
View Channel →
A PureTech startup banks $180M for a new IPF drug
Source ↗ 👁 0 💬 0
Celea, backed by investors such as RA Capital and Leaps by Bayer, is making what it says is an improved version of Roche's Esbriet.

Comments (0)

Sign in to join the discussion

More Like This

'Very dangerous' super typhoon nears US Pacific islands
Earth News - Earth Science News, Earth Science, Climate Change · 16h ago
'This was something new': What people in Greenland told us about learning to live with wildfires
Earth News - Earth Science News, Earth Science, Climate Change · 22h ago
Trump victorious in legal battle to erase climate change and slavery signs from national parks
EHN · 1d ago
Australia welcomes draft UNESCO decision to keep Great Barrier Reef off danger list
EHN · 1d ago
Extreme heat is not an equal-opportunity killer
EHN · 1d ago
Trump pardons violators of the Clean Air Act
EHN · 1d ago